Co-prescription of medication for bipolar disorder and diabetes mellitus: A nationwide population-based study with focus on gender differences

BMC Medicine

Volumn 10, Issue , 2012, Pages

  Svendal, Gjertrud ^a,b   Fasmer, Ole B ^a,b   Engeland, Anders ^a,c   Berk, Michael ^d,e,f   Lund, Anders ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d DEAKIN UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; INSULIN; LAMOTRIGINE; LITHIUM; ORAL ANTIDIABETIC AGENT; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POPULATION RESEARCH; PRESCRIPTION; RISK ASSESSMENT; SEX DIFFERENCE;

ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; SEX FACTORS; YOUNG ADULT;

EID: 84869862823     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-10-148     Document Type: Article

References (28)

1. Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999, 156:1417-1420.
2. Lilliker SL. Prevalence of diabetes in a manic-depressive population. Compr Psychiatry 1980, 21:270-275. 10.1016/0010-440X(80)90030-9, 7398250.
3. Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 2002, 70:19-26. 10.1016/S0165-0327(01)00456-6, 12113916.
4. Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, Miller DD, Haynes WG. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry 2008, 20:131-137. 10.1080/10401230802177722, 2776768, 18633739.
5. Hert MD, Dekker JM, Wood D, Kahl KG, Holt RIG, Möller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009, 24:412-424. 10.1016/j.eurpsy.2009.01.005, 19682863.
6. Berge LI, Riise T, Fasmer OB, Lund A, Oedegaard KJ, Hundal O. Risk of depression in diabetes is highest for young persons using oral anti-diabetic agents. Diabet Med 2011, 29:509-514.
7. Fasmer OB, Riise T, Eagan TM, Lund A, Dilsaver SC, Hundal O, Oedegaard KJ. Comorbidity of asthma with ADHD. J Atten Disord 2011, 15:564-571. 10.1177/1087054710372493, 20574059.
8. Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD) - new opportunities for research in pharmacoepidemiology in Norway. Norsk Epidemiol 2008, 18:129-136.
9. Oedegaard KJ, Riise T, Dilsaver SC, Lund A, Akiskal HS, Fasmer OB, Hundal O. A pharmaco-epidemiological study of migraine and antidepressant medications: complete one year data from the Norwegian population. J Affect Disord 2011, 129:198-204. 10.1016/j.jad.2010.09.009, 20889212.
10. Ruzickova M, Slaney C, Garnham J, Alda M. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can J Psychiatry 2003, 48:458-461.
11. Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 2006, 68:684-691. 10.1097/01.psy.0000237316.09601.88, 17012521.
12. Kessing LV, Nilsson FM, Siersma V, Andersen PK. Increased risk of developing diabetes in depressive and bipolar disorders?. J Psychiatr Res 2004, 38:395-402. 10.1016/j.jpsychires.2003.12.001, 15203291.
13. McIntyre RS, Konarski JZ, Misener VL, Kennedy SH. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry 2005, 17:83-93. 10.1080/10401230590932380, 16075661.
14. Dessein PH, Stanwix AE, Joffe BI. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 2002, 4:R5. 10.1186/ar428, 125299, 12223108.
15. Silveri F, Brecciaroli D, Argentati F, Cervini C. Serum levels of insulin in overweight patients with osteoarthritis of the knee. J Rheumatol 1994, 21:1899-1902.
16. Sturmer T, Brenner H, Brenner RE, Gunther KP. Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis. The Ulm Osteoarthritis Study. Scand J Rheumatol 2001, 30:169-171. 10.1080/030097401300162969, 11469529.
17. Pasco JA, Nicholson GC, Ng F, Henry MJ, Williams LJ, Kotowicz MA, Hodge JM, Dodd S, Kapczinski F, Gama CG, Berk M. Oxidative stress may be a common mechanism linking major depression and osteoporosis. Acta Neuropsychiatrica 2008, 20:112-116.
18. Chen G, Huang L, Y J, HK M. The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3. J Neurochem 2008, 72:1327-1330.
19. Ryves WJ, Harwood AJ. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 2001, 280:720-725. 10.1006/bbrc.2000.4169, 11162580.
20. Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M, Altamura C, Galecki P, Berk M. (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:659-663. 10.1016/j.pnpbp.2011.02.019, 21376099.
21. Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, Schneider HG, Leonard BE, Berk M. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry 2010, 197:372-377. 10.1192/bjp.bp.109.076430, 21037214.
22. Carulli L, Rondinella S, Lombardini S, Canedi I, Loria P, Carulli N. Review article: diabetes, genetics and ethnicity. Aliment Pharmacol Ther 2005, 22:16-19. 10.1111/j.1365-2036.2005.02588.x, 16225465.
23. Craddock N, Sklar P. Genetics of bipolar disorder: successful start to a long journey. Trends Genet 2009, 25:99-105. 10.1016/j.tig.2008.12.002, 19144440.
24. Haack S, Seeringer A, Thürmann PA, Becker T, Kircheiner J. Sex-specific differences in side effects on psychotropic drugs: genes or gender?. Pharmacogenomics 2009, 10:1511-1526. 10.2217/pgs.09.102, 19761372.
25. Dixon L, Wieden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, Lehman A. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000, 26:903-912. 10.1093/oxfordjournals.schbul.a033504, 11087022.
26. Gallego JA, Bonetti J, Zhang J, Kane JM, Correll CU. Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophr Res 2012, 138:18-28. 10.1016/j.schres.2012.03.018, 22534420.
27. Clark RE, Bartels SJ, Mellman TA, Peacock WJ. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorders: Implications for state mental health policy. Schizophr Bull 2002, 28:75-84. 10.1093/oxfordjournals.schbul.a006928, 12047024.
28. Smith M, Hopkins D, Peveler RC, Holt RI, Woodward M, Ismail K. First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2008, 192:406-411. 10.1192/bjp.bp.107.037184, 18515889.